Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

A genome-wide CRISPR screen identifies the TNRC18 gene locus as a regulator of inflammatory signaling

Submitted by Viola Mäkelä on Mon, 10/16/2023 - 12:59
  • Read more about A genome-wide CRISPR screen identifies the TNRC18 gene locus as a regulator of inflammatory signaling

Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: A Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:47
  • Read more about Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: A Mendelian randomization study

Low levels of small HDL particles predict but do not influence risk of sepsis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:43
  • Read more about Low levels of small HDL particles predict but do not influence risk of sepsis

Correlation study of malignant lymphoma and breast Cancer in different gender European populations: mendelian randomization analysis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:41
  • Read more about Correlation study of malignant lymphoma and breast Cancer in different gender European populations: mendelian randomization analysis

A Mendelian randomization-based approach to explore the relationship between leukocyte counts and breast cancer risk in European ethnic groups

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:31
  • Read more about A Mendelian randomization-based approach to explore the relationship between leukocyte counts and breast cancer risk in European ethnic groups

Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: a Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:25
  • Read more about Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: a Mendelian randomization study

Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:21
  • Read more about Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study

Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:56
  • Read more about Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis

The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:51
  • Read more about The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses

Causal relationship between blood metabolites and risk of five infections: a Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:22
  • Read more about Causal relationship between blood metabolites and risk of five infections: a Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 381
  • Page 382
  • Page 383
  • Page 384
  • Current page 385
  • Page 386
  • Page 387
  • Page 388
  • Page 389
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement